Ozanimod in relapsing multiple sclerosis: Pooled safety results from the clinical development program

Autor: Selmaj, Krzysztof W., Cohen, Jeffrey A, Comi, Giancarlo, Bar-Or, Amit, Arnold, Douglas L, Steinman, Lawrence, Hartung, Hans Peter, Montalban, Xavier, Havrdova, Eva Kubala, Cree, Bruce A.C., Minton, Neil, Sheffield, James K, Ding, Ning, Kappos, Ludwig
Zdroj: In Multiple Sclerosis and Related Disorders June 2021 51
Databáze: ScienceDirect